Caution in Use – Grepid 75 mg film coated tablets

27th June 2024

27th June 2024

Dear Customer

Pharmathen S.A. has issued a Class 4 Medicines Defect Information – Caution in Use. In relation to:

Grepid 75 mg film coated tablets (Kent Pharma Livery) -PLGB 17277/0398

There is no impact to the product quality or safety and due to considerations that clopidogrel is only available as a Prescription Only Medicine, these batches are not being recalled.

This notification is to advised Healthcare professionals to exercise caution when handling the listed product. The affected batches of the product simply have ‘POM’ missing from the outer carton (box).  The caution in use requirement is to flag this, to ensure that they stored accordingly and in line with the guidance for the storage of Prescription Only Medicines (POM).

The following details how the affected batches purchased through NVS were sold as.


NVS Product Code(s) Product Description Expiry Date Affected Batch Numbers
340765 CLOPIDOGREL TABS 75MG, PK 28 07/2025 1206041


What to do next – Please read the attached notification letter (Please click here) and bring the issue to the attention of all relevant colleagues within your business.